Cargando…
Repeated radioembolization in advanced liver cancer
BACKGROUND: To evaluate safety and clinical outcome of repeated transarterial (90)Y (yttrium) radioembolization (TARE) in primary and metastatic liver cancer. METHODS: Between 2009 and 2018, n=288 patients underwent TARE for treatment of malignant liver disease in a tertiary care hospital. This retr...
Autores principales: | Masthoff, Max, Schindler, Philipp, Harders, Fabian, Heindel, Walter, Wilms, Christian, Schmidt, Hartmut H., Pascher, Andreas, Stegger, Lars, Rahbar, Kambiz, Wildgruber, Moritz, Köhler, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575953/ https://www.ncbi.nlm.nih.gov/pubmed/33145274 http://dx.doi.org/10.21037/atm-20-2658 |
Ejemplares similares
-
Analysis of failed therapy evaluations in radioembolization of primary and secondary liver cancers
por: Masthoff, Max, et al.
Publicado: (2020) -
Prognostic Factors for Overall Survival in Advanced Intrahepatic Cholangiocarcinoma Treated with Yttrium-90 Radioembolization
por: Köhler, Michael, et al.
Publicado: (2019) -
Multi-organ Radiomics-Based Prediction of Future Remnant Liver Hypertrophy Following Portal Vein Embolization
por: Gerwing, Mirjam, et al.
Publicado: (2023) -
Intraosseous contrast administration for emergency computed tomography: A case-control study
por: Schindler, Philipp, et al.
Publicado: (2019) -
TIPS Modification in the Management of Shunt-Induced Hepatic Encephalopathy: Analysis of Predictive Factors and Outcome with Shunt Modification
por: Schindler, Philipp, et al.
Publicado: (2020)